RealFeedApp New protein molecules reduce toxicity
Researchers are developing novel molecule classes, including ADCs and multispecific antibodies, which promise better selectivity and lower tissue damage compared to existing treatments.
- Field
- drugs and trials
- What they did
- Researchers described new classes of protein molecules, including antibody-drug conjugates, which are more effective and safer than existing cancer treatments.
- Why it matters
- This could help cancer patients receive more targeted drug effects with less toxic side effects.
#antibody-drug conjugates#oncology#protein therapeutics#clinical trials
